The myeloma genome project and the aim to disseminate this worldwide
The road to individualized treatment for CLL
Obinutuzumab and venetoclax for high-risk CLL: upcoming CLL14 trial
Follow-up results of looking at treatment with ibrutinib on CLL patient survival and adverse events
How does an understanding of the microenvironment aid research in CLL?